Key result
Mitral valve repair for active-phase infective endocarditis resulted in smaller postoperative left ventricular end-diastolic dimension (45.7 vs 53.3 mm) compared to valve replacement.
Why the study?
Does mitral valve repair improve postoperative left ventricular dimensions and ejection fraction compared to replacement in patients with active-phase infective endocarditis?
Population
22 patients undergoing native mitral valve operations during active-phase infective endocarditis
Comparison
Mitral valve repair vs Mitral valve replacement
Design
Cohort
Authors
Loading...
May support repair consideration in active-phase IE for LV preservation; hypothesis-generating and should not yet change practice without RCTs.
Observational (n=22)
Does mitral valve repair improve postoperative left ventricular dimensions and ejection fraction compared to replacement in patients with active-phase infective endocarditis?
Absolute Event Rate: 45.7% vs 53.3%
Mitral valve repair is feasible in active-phase infective endocarditis and improves postoperative left ventricular dimensions and ejection fraction compared to replacement, though long-term durability may be a concern.
Omoto et al. (2011) conducted an observational in active-phase infective endocarditis (n=22). Mitral valve repair vs. Mitral valve replacement was evaluated on Postoperative left ventricular end-diastolic dimension (mm). Mitral valve repair for active-phase infective endocarditis resulted in smaller postoperative left ventricular end-diastolic dimension (45.7 vs 53.3 mm) compared to valve replacement.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: